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Cardiac output, arterial elastance, left ventricular end-diastolic pressure (LVEDP) and
end-systolic volume showed no obvious changes. Little changes occurred in ejection
fraction except that there was a decreasing in acute exhaustive rats. There were no
signiﬁcant differences between two groups at dp/dtmax, stroke work and the slope of
the end-systolic P-V relation (ESPVR). The parameters used to evaluate the diastolic
including Tau, -dp/dtmin and the slope of the end- diastolic P-V relation (EDPVR). Tau
was 15.893.53 ms in acute exhaustive group increased obviously (P<0.01)
compared with 6.491.26 ms in Control group. P-V loops moved to the right and
down portion of the coordinate system.
Conclusions: Epinephrine and norepinephrine increase compensatorily after
exhaustive swimming. Exhaustive swimming induces acute exhaustive lesion both in
systolic function and diastolic function in rats.
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Objectives: To observe the effect of Ginsenoside Rb1 on the brain tissue of natural
aging mouse, as well as to explore the connection between Rb1 and mTOR/p70S6K
pathway.
Methods: Twenty-seven mice were obtained from the Animal Experiment Center of
Sun Yat-sun University. Four-month-old mice was termed as the young group (n¼7),
and 22-month-old mice was as the old groups (n¼20). PBS was administered intra-
peritoneally to the young group, and old groups were injected intraperitoneally with
PBS (old controls), low dose (10mg/kg) Rb1 and high dose (20mg/kg) Rb1, respec-
tively. The mice were sacriﬁced 6 weeks after intraperitoneal administration. Mice
brain tissues were obtained to examine the activity of MAO and the protein expression
of Plasminogen activator inhibitor 1 (PAI-1), P-mTOR/ mTOR (Mammalian Target
Of Rapamycin) and P-p70S6K/ p70S6K.
Results: In the brain tissues of old controls, the activity of MAO and expression of
PAI-1 were increased signiﬁcantly, with a high phosphorylation level of mTOR and
its target p70S6K, compared with young group. However, the activity of MAO and
phosphorylation level of mTOR were decreased in brains of both Rb1 group mice;
Furthermore, obvious decrease in the expression of PAI-1 and phosphorylation level
of p70S6K of high-dose-group mice brain was observed, compared with old controls.
Conclusions: Ginsenoside Rb1 prevents mice against natural aging-related changes in
activity of MAO and expression of PAI-1, and high-dose group was superior to
low-dose group. The anti-aging effect of Ginsenoside Rb1 is highly associated with
mTOR/p70S6K pathway.
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Objectives: QiShen YiQi Pills (QSYQ) is a compound Chinese medicine used for
treatment of cardiovascular diseases, and can inhibit cardiac ﬁbrosis in left ventricle
hypertrophy. This study was to investigate the potential antiﬁbrotic effects and
mechanisms of QSYQ in the isoproterenol- induced myocardial ﬁbrosis in rats.
Methods: We studied a normal control group and 2 groups of rats undergoing
isoproterenol-induced myocardial ﬁbrosis 1 week prior to treatment: isoproterenol
(ISO) group, and ISO combined with QSYQ (ISO+QSYQ) group. The rats of ISO and
ISO+QSYQ group were received ISO (120 mg/Kg BW) by subcutaneous injection
at two consecutive days. After 7d for ISO treatment, Vehicle (water) or QSYQ
(250mg/kg/d) was administered by gavage for 28d. After treatment for successive 28
days, hemodynamic parameters were measured by echocardiography and the histo-
pathological changes of cardiac tissue was observed via hematoxylin/eosin and
Masson’s trichrome reagent staining. The expression of matrix metalloproteinases
(MMP-9), tissue inhibitor of matrix metalloproteinase 1 (TIMP-1), collagen I and III
in left and right ventricle (LV and RV) tissues was detected by Western blot.
Results: QSYQ signiﬁcantly improved left systolic functions, resulting in improved
LV ejection fraction (74.93.95% vs 61.24.14%; P<0.01), fractional shortening
(44.93.58% vs 37.72.67%; P<0.01), LV internal dimension in systole (P<0.05).
Masson’s trichrome staining in ISO treated group reveals increased cardiac interstitial
ﬁbrosis (10.52%0.98%), while treatment with QSYQ resulted in reversal of
myocardial ﬁbrosis (7.07%0.82%). QSYQ also obviously reduced the expression of
collagen I and III content in the whole LV and RV tissues respectively. QSYQ treated
rats decreased remarkably the expression of MMP9 and TIMP-1 in LV and RV tissues
as compared with the rats in ISO treated group.
Conclusions: QSYQ can improves cardiac function and prevents cardiac remodeling
in the late stage after ISO induced myocardial ﬁbrosis, and the mechanisms maybe
associate with regulate MMP-9/TIMP-1 imbalance in ventricle tissue of rat heart. It
obviously suggests that QSYQ may be considered an antiﬁbrotic drug for the
improvement of post-MI myocardial dysfunction and remodeling.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BGW25-e4240
Resveratrol prevention of diabetes-induced cardiorenal damage was associated
with the suppression of oxidative stress and inﬂammation: roles of Nrf2
and NF-kB
Wang Yuehui1, Zhao Huiying1, Liu Yingying1, Ma Xiaojuan1, Cai Lu2
1The First Hospital of Jilin University, 2University of Louisville
Objectives: Cardiorenal complications are common and serious complications in
diabetes. Oxidative stress plays an important role in diabetes-induced cardiorenal
damage and pathogenesis. Nuclear factor E2-related factor-2 (Nrf2) is a transcription
factor antioxidant to oxidative stress, and nuclear factor-kB (NF-kB) is pathogenically
signiﬁcant in inﬂammation. In the present study, we tested whether Resveratrol (RSV)
can protect heart and kidney from diabetes, if so, whether the cardiorenal protection by
RSV is associated with Nrf2 and NF-kB.
Methods: Type 1 diabetes was induced in FVB mice by multiple low-dose strepto-
zotocin. Diabetic and age-matched control mice were treated with or without RSV by
oral gavage at 10 mg/kg/day for 12 weeks. Hearts and kidneys from these mice were
respectively assessed for ﬁbrosis, inﬂammation, oxidative damage, and Nrf2 expres-
sion and transcription by immunohistochemical staining and real-time PCR method.
Results: Diabetes induced signiﬁcant increases in oxidative stress and inﬂammation in
the hearts and kidneys at 3 months. RSV attenuated these diabetic cardiorenal path-
ogenic changes, signiﬁcantly up-regulated the expression of Nrf2 and its down-stream
antioxidants, and also down-regulated the expression of NF-kB and mediated
inﬂammation.
Conclusions: The cardiorenal protection from diabetes by RSV was associated with
the up-regulation of Nrf2 and its downstream antioxidants, also associated with down-
regulation of NF-kB.
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Objectives: Wenxin granule (WXG), a Chinese herbal compound, has been widely
applied in protecting myocardial cells and reducing ventricular arrhythmia (VA) after
myocardial infarction. Its mechanism of preventing ischemic ventricular arrhythmia,
however, is less well-established. Since connexin 43 (Cx43) has been proposed to be
involved in VA’s protection, the present study analyzed whether WXG prevent VA
during acute myocardial ischemia and reperfusion by up-regulating Cx43 expression
and decreasing heterogeneity and lateralization of Cx43 distribution.
Methods: Sixty male Wistar rats were randomly divided into sham group (N¼15),
control group (N¼15), low dosage group with 2.43g WXG per kg of body weight
(N¼15), high dosage group with 9.72g WXG per kg of body weight (N¼15). WXG
was administrated by gastric perfusion. Besides sham group, left descending anterior
coronary artery in other groups were subjected to 30 min of regional ischemia and 2 h
of reperfusion. Each rats was monitored by electrocardiogram machine, and
arrhythmia scores were assigned during the ten 3-min intervals of myocardial
ischemia. The tissue specimen was then evaluated by immunohistochemistry and
Western blot.
Results: WXG signiﬁcantly reduced ventricular arrhythmic events (ventricular
tachycardia times per minute respectively in control group, low dose group and high
dose group: 5.86  1.28, 4.14  0.67 and 2.17 0.80, P<0.001; ventricular ﬁbril-
lation times per minute respectively in control group, low dose group and high dose
group: 1.13  0.44, 0.44  0.23 and 0.060.01, P<0.001) and shortened duration of
arrhythmia (P<0.001). Additionally, Control animals had an average arrhythmia score
of 5.40  1.22. WXG compared with the control group signiﬁcantly reduced the
arrhythmia score during 30 min of ischemia (low dose and high dose group, 3.21 
0.65 and 2.42  0.32; P<0.001). HE staining showed WXG could decrease the infarct
size and attenuated cardiomyocyte apoptosis. More heterogeneous and lateralized
Cx43 distribution was observed in control group compared with WXG group. Western
blot showed less expression of Cx43 in control group, and there was a signiﬁcant
association between WXG dose and reduced VA’s events (P<0.001).
Conclusions:WXG prevent VA during acute myocardial ischemia and reperfusion by
up-regulating Cx43 expression and decreasing heterogeneity and lateralization of
Cx43 distribution.
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Objectives: Renal denervation (RD) has been shown to be effective in treating post-
myocardial Infarction (MI) heart failure (HF) in animal models and clinical trials. This
study was designed to further assess the difference of effectiveness and safety between
RD and conventional medicine therapy in rats with post-MI HF.
Methods: Rats were randomly assigned into seven experimental groups: N group
(control group with no MI and no RD, n¼10), MI group (MI, n¼20), RD group (renalasic and Translational Medicine C81
